ArticleAesthetic surgery journal. Open forum2025
Recommendations on Periprocedural Skincare for Energy-Based Dermatologic Procedures.
Article in Aesthetic surgery journal. Open forum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- International Expert Consensus on Integrated Skincare Active Ingredients for Pretreatment and Posttreatment Use With Medical Aesthetic Procedures to Enhance Skin Benefits.Journal of cosmetic dermatology · 2026Article
- Clinical Efficacy of a Flavo-Proxylane Topical Regimen Pre- and Post-ultrasound Procedure for Subjects Undergoing Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Therapy.Dermatology and therapy · 2026Article
- Fractional COClinical, cosmetic and investigational dermatology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The use of energy-based device (EBD) aesthetic skin treatments is increasing in popularity. Implementation of periprocedural skincare may improve treatment-related outcomes, reduce recovery time, and reduce the frequency and severity of potential side effects. This review presents treatment recommendations to assist clinicians in optimizing integrated skincare to enhance EBD treatment outcomes. A panel of Australian 6 physicians (5 dermatologists, 1 plastic surgeon) developed 4 generalized EBD periprocedural skincare recommendations. These recommendations were divided based on 4 levels of skin barrier disruption caused by EBD treatment: none (or minimal), mild, moderate, and severe barrier disruption. The greater the disruption caused to the skin barrier, the greater care needed in choosing appropriate skincare products with suitable actives. Preprocedural skincare incorporating moisturizers, broad-spectrum sun-protection factor 50+ sunscreen, antioxidants, and niacinamide should be implemented at least 2 weeks before treatment to enhance skin barrier function and hydration. Postprocedure recommendations are made for the use of appropriate skincare actives that promote barrier repair and avoid further irritation. Prescription actives should be avoided for an appropriate period following EBD procedures; this period is dependent on the EBD treatment type and degree of skin barrier disruption it can cause. The algorithms provided here are aimed to assist clinicians in optimizing integrated skincare recommendations to enhance EBD treatment outcomes, promote healing, and reduce the likelihood of adverse events. Skincare recommendations made to patients should be based on the condition of the patient's skin, as well as the magnitude of skin barrier disruption caused by the EBD procedure. Level of Evidence 5 Therapeutic:
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.